You're contacting media contact of this press release

Title: Neuralia TMS Delivers Magnetic Stimulation Therapy for Post-Traumatic Stress

Australia, 26th Aug 2026 - Neuralia TMS, a respected provider of transcranial magnetic stimulation therapy, has confirmed that treatment for post-traumatic stress disorder forms an established part of clinical activity at its Moonee Ponds practice, where non-invasive neuromodulation is administered to patients referred with trauma-related symptoms. The clinic reports sustained enquiry levels from general practitioners, psychiatrists and patients seeking drug-free options, reflecting continued demand for structured treatment pathways beyond medication and psychological therapy alone.Transcranial magnetic stimulation uses magnetic fields, generated by a coil positioned against the scalp, to stimulate nerve cells in regions of the brain associated with mood regulation and threat response. The procedure is carried out while the patient remains awake and seated, without anaesthetic or sedation, and patients are generally able to resume ordinary activities, including driving, once a session concludes. Individual sessions run for a set period on consecutive weekdays across several weeks, with the precise protocol determined during clinical assessment rather than applied uniformly.Post-traumatic stress disorder can develop following exposure to a traumatic event and is commonly associated with intrusive memories, avoidance behaviours, disturbed sleep, heightened alertness and changes in mood. In Australia, presentations frequently involve veterans, current and former emergency services personnel, survivors of accidents or assault, and people affected by prolonged interpersonal trauma. Clinical guidelines generally position trauma-focused psychological therapy as an initial step, with medication considered where symptoms persist. Neuromodulation is typically applied where sympto...

This press release is issued by King Newswire